{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:33:18Z","timestamp":1771054398617,"version":"3.50.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00115-018-0581-6","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T10:31:30Z","timestamp":1534761090000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antipsychotikaassoziierte motorische Symptome bei schizophrenen Psychosen \u2013 Teil\u00a02","Antipsychotic-induced motor symptoms in schizophrenic psychoses\u2014Part\u00a02"],"prefix":"10.1007","volume":"90","author":[{"given":"D.","family":"Hirjak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Kubera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. C.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"issue":"1","key":"581_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00115-017-0375-2","volume":"89","author":"D Hirjak","year":"2018","unstructured":"Hirjak D et\u00a0al (2018) Genuine motor phenomena in schizophrenic psychoses: theoretical background and definition of context. Nervenarzt 89(1):44\u201350","journal-title":"Nervenarzt"},{"issue":"1","key":"581_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00115-017-0434-8","volume":"89","author":"D Hirjak","year":"2018","unstructured":"Hirjak D et\u00a0al (2018) Genuine motor phenomena in schizophrenia: neuronal correlates and pathomechanisms. Nervenarzt 89(1):27\u201343","journal-title":"Nervenarzt"},{"key":"581_CR3","volume-title":"Internationale Klassifikation psychischer St\u00f6rungen: ICD-10 Kapitel V (F) \u2013 Klinisch-diagnostische Leitlinien","author":"H Dilling","year":"2015","unstructured":"Dilling H et al (2015) Internationale Klassifikation psychischer St\u00f6rungen: ICD-10 Kapitel V (F) \u2013 Klinisch-diagnostische Leitlinien, 10.\u00a0Aufl. Hogrefe, G\u00f6ttingen","edition":"10"},{"issue":"2","key":"581_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","volume":"23","author":"ML England","year":"2011","unstructured":"England ML et\u00a0al (2011) Catatonia in psychotic patients: clinical features and treatment response. J\u00a0Neuropsychiatry Clin Neurosci 23(2):223\u2013226","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"581_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/10401230701844786","volume":"20","author":"R Seethalakshmi","year":"2008","unstructured":"Seethalakshmi R et\u00a0al (2008) Catatonic syndrome: importance of detection and treatment with lorazepam. Ann Clin Psychiatry 20(1):5\u20138","journal-title":"Ann Clin Psychiatry"},{"issue":"2","key":"581_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/schbul\/sbp141","volume":"36","author":"PI Rosebush","year":"2010","unstructured":"Rosebush PI, Mazurek MF (2010) Catatonia and its treatment. Schizophr Bull 36(2):239\u2013242","journal-title":"Schizophr Bull"},{"issue":"4","key":"581_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","volume":"6","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen SA, Mazurek MF, Rosebush Catatonia PI (2016) Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry 6(4):391\u2013398","journal-title":"World J Psychiatry"},{"key":"581_CR8","first-page":"697428","volume":"2015","author":"HM Poser","year":"2015","unstructured":"Poser HM, Trutia AE (2015) Treatment of a\u00a0Prader-Willi patient with recurrent catatonia. Case Rep Psychiatry 2015:697428","journal-title":"Case Rep Psychiatry"},{"issue":"3","key":"581_CR9","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1176\/appi.neuropsych.11070169","volume":"24","author":"RB Nayak","year":"2012","unstructured":"Nayak RB et\u00a0al (2012) Catatonia: a\u00a0rare presenting symptom of Wilson\u2019s disease. J\u00a0Neuropsychiatry Clin Neurosci 24(3):E34\u20135","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"581_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1192\/bjp.195.3.272","volume":"195","author":"RN Cardinal","year":"2009","unstructured":"Cardinal RN et\u00a0al (2009) Psychosis and catatonia as a\u00a0first presentation of antiphospholipid syndrome. Br J Psychiatry 195(3):272","journal-title":"Br J Psychiatry"},{"issue":"3","key":"581_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.pra.0000398417.97609.2e","volume":"17","author":"S Pustilnik","year":"2011","unstructured":"Pustilnik S, Trutia A (2011) Catatonia as the presenting symptom in systemic lupus erythematosus. J\u00a0Psychiatr Pract 17(3):217\u2013221","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"581_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.yct.0000244241.02544.49","volume":"22","author":"K Suzuki","year":"2006","unstructured":"Suzuki K et\u00a0al (2006) Hysteria presenting as a\u00a0prodrome to catatonic stupor in a\u00a0depressive patient resolved with electroconvulsive therapy. J\u00a0Ect 22(4):276","journal-title":"J Ect"},{"issue":"8190","key":"581_CR13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0140-6736(80)90377-3","volume":"2","author":"M Dhadphale","year":"1980","unstructured":"Dhadphale M (1980) Eye gaze diagnostic sign in hysterical stupor. Lancet 2(8190):374\u2013375","journal-title":"Lancet"},{"key":"581_CR14","volume-title":"Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen \u2013 DSM-5 \u00ae: Deutsche Ausgabe","author":"P Falkai","year":"2014","unstructured":"Falkai P et al (2014) Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen \u2013 DSM-5 \u00ae: Deutsche Ausgabe, 1.\u00a0Aufl. Hogrefe, G\u00f6ttingen","edition":"1"},{"issue":"5","key":"581_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00115-013-3985-3","volume":"85","author":"M Paulzen","year":"2014","unstructured":"Paulzen M, Schneider F (2014) Schizophrenia and other psychotic disorders in DSM-5: summary of the changes compared to DSM-IV. Nervenarzt 85(5):533\u2013542","journal-title":"Nervenarzt"},{"issue":"1\u20133","key":"581_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.schres.2014.12.036","volume":"164","author":"JE Wilson","year":"2015","unstructured":"Wilson JE et\u00a0al (2015) The diagnostic criteria and structure of catatonia. Schizophr Res 164(1\u20133):256\u2013262","journal-title":"Schizophr Res"},{"issue":"1","key":"581_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.1973.01750310023005","volume":"28","author":"JR Morrison","year":"1973","unstructured":"Morrison JR (1973) Catatonia. Retarded and excited types. Arch Gen Psychiatry 28(1):39\u201341","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"581_CR18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbp059","volume":"36","author":"M Fink","year":"2010","unstructured":"Fink M, Shorter E, Taylor MA (2010) Catatonia is not schizophrenia: Kraepelin\u2019s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 36(2):314\u2013320","journal-title":"Schizophr Bull"},{"key":"581_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","volume":"5","author":"P Sienaert","year":"2014","unstructured":"Sienaert P et\u00a0al (2014) A clinical review of the treatment of catatonia. Front Psychiatry 5:181","journal-title":"Front Psychiatry"},{"key":"581_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-642-83654-1_16","volume-title":"Katatone und dyskinetische Syndrome","author":"HJ M\u00f6ller","year":"1989","unstructured":"M\u00f6ller HJ (1989) Medikament\u00f6se Therapie der katatonen Schizophrenie. In: Hippius H, R\u00fcther E, Schmau\u00df M (Hrsg) Katatone und dyskinetische Syndrome. Springer, Berlin, Heidelberg, S\u00a0157\u2013163"},{"issue":"10","key":"581_CR21","first-page":"1366","volume":"162","author":"MD Andreassen","year":"2000","unstructured":"Andreassen MD, Pedersen S (2000) Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS. Ugeskr Laeg 162(10):1366\u20131370","journal-title":"Ugeskr. Laeg."},{"issue":"3","key":"581_CR22","first-page":"79","volume":"41","author":"SN Caroff","year":"1980","unstructured":"Caroff SN (1980) The neuroleptic malignant syndrome. J\u00a0Clin Psychiatry 41(3):79\u201383","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"581_CR23","first-page":"477","volume":"21","author":"SN Caroff","year":"1993","unstructured":"Caroff SN, Mann SC (1993) Neuroleptic malignant syndrome and malignant hyperthermia. Anaesth Intensive Care 21(4):477\u2013478","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"581_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","volume":"77","author":"SN Caroff","year":"1993","unstructured":"Caroff SN, Mann SC (1993) Neuroleptic malignant syndrome. Med Clin North Am 77(1):185\u2013202","journal-title":"Med Clin North Am"},{"issue":"10","key":"581_CR25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142(10):1137\u20131145","journal-title":"Am J Psychiatry"},{"issue":"12","key":"581_CR26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0033-3182(85)72761-2","volume":"26","author":"AL Pelonero","year":"1985","unstructured":"Pelonero AL, Levenson JL, Silverman JJ (1985) Neuroleptic therapy following neuroleptic malignant syndrome. Psychosomatics 26(12):946\u2013947","journal-title":"Psychosomatics"},{"issue":"11","key":"581_CR27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1176\/ajp.155.11.1626v","volume":"155","author":"KG Rasmussen","year":"1998","unstructured":"Rasmussen KG (1998) Risk factors for neuroleptic malignant syndrome. Am J Psychiatry 155(11):1639 (author reply 1639\u201340)","journal-title":"Am J Psychiatry"},{"issue":"7","key":"581_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0035-1553246","volume":"83","author":"M Nagel","year":"2015","unstructured":"Nagel M et\u00a0al (2015) The neuroleptic malignant syndrome. Fortschr Neurol Psychiatr 83(7):373\u2013380","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"4","key":"581_CR29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0924-2708.2004.00085.x","volume":"16","author":"J Ananth","year":"2004","unstructured":"Ananth J et\u00a0al (2004) Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. Acta Neuropsychiatr 16(4):219\u2013228","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"581_CR30","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc5148","volume":"11","author":"U Reulbach","year":"2007","unstructured":"Reulbach U et\u00a0al (2007) Managing an effective treatment for neuroleptic malignant syndrome. Crit Care 11(1):R4","journal-title":"Crit Care"},{"issue":"5","key":"581_CR31","first-page":"576","volume":"33","author":"MC Tsai","year":"2010","unstructured":"Tsai MC, Huang TL (2010) Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a\u00a0case report. Chang Gung Med\u00a0J 33(5):576\u2013580","journal-title":"Chang Gung Med J"},{"issue":"3","key":"581_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.rpsm.2011.04.005","volume":"4","author":"EJ Verdura Vizcaino","year":"2011","unstructured":"Verdura Vizcaino EJ, Ballesteros Sanz D, Sanz-Fuentenebro J (2011) Electroconvulsive therapy as treatment for malignant neuroleptic syndrome. Rev Psiquiatr Salud Ment 4(3):169\u2013176","journal-title":"Rev Psiquiatr Salud Ment"},{"issue":"2","key":"581_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jen.2017.11.008","volume":"44","author":"CJ Whyte","year":"2018","unstructured":"Whyte CJ, Rosini JM (2018) Dantrolene for treatment of suspected neuroleptic malignant syndrome. J\u00a0Emerg Nurs 44(2):207\u2013209","journal-title":"J Emerg Nurs"},{"issue":"2","key":"581_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","volume":"93","author":"G Bush","year":"1996","unstructured":"Bush G et\u00a0al (1996) Catatonia. II. Treatment with iorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93(2):137\u2013143","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"581_CR35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0019-5545.75559","volume":"53","author":"A Dutt","year":"2011","unstructured":"Dutt A et\u00a0al (2011) Phenomenology and treatment of catatonia: a descriptive study from North India. Indian J Psychiatry 53(1):36\u201340","journal-title":"Indian J Psychiatry"},{"issue":"4","key":"581_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/yct.0b013e3181587949","volume":"23","author":"K Hatta","year":"2007","unstructured":"Hatta K et\u00a0al (2007) Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J\u00a0Ect 23(4):233\u2013235","journal-title":"J Ect"},{"issue":"3","key":"581_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S1461145701002486","volume":"4","author":"PR Kritzinger","year":"2001","unstructured":"Kritzinger PR, Jordaan GP (2001) Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol 4(3):251\u2013257","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"581_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/10401230009147094","volume":"12","author":"JW Lee","year":"2000","unstructured":"Lee JW, Schwartz DL, Hallmayer J (2000) Catatonia in a\u00a0psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 12(2):89\u201396","journal-title":"Ann Clin Psychiatry"},{"issue":"8","key":"581_CR39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.comppsych.2013.06.003","volume":"54","author":"CC Lin","year":"2013","unstructured":"Lin CC, Huang TL (2013) Lorazepam-diazepam protocol for catatonia in schizophrenia: a\u00a021\u2013case analysis. Compr Psychiatry 54(8):1210\u20131214","journal-title":"Compr Psychiatry"},{"issue":"3","key":"581_CR40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.genhosppsych.2012.01.011","volume":"34","author":"JC Narayanaswamy","year":"2012","unstructured":"Narayanaswamy JC et\u00a0al (2012) Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry 34(3):312\u2013316","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"581_CR41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02246093","volume":"122","author":"G Northoff","year":"1995","unstructured":"Northoff G et al (1995) Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology (Berl) 122(2):182\u2013186","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"581_CR42","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.pnpbp.2010.08.017","volume":"34","author":"P Tibrewal","year":"2010","unstructured":"Tibrewal P et\u00a0al (2010) Response rate of lorazepam in catatonia: a\u00a0developing country\u2019s perspective. Prog Neuropsychopharmacol Biol Psychiatry 34(8):1520\u20131522","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"581_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050904","volume":"142","author":"GS Ungvari","year":"1999","unstructured":"Ungvari GS et al (1999) Lorazepam for chronic catatonia: a\u00a0randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl) 142(4):393\u2013398","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"581_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0447.1994.tb01515.x","volume":"89","author":"GS Ungvari","year":"1994","unstructured":"Ungvari GS et\u00a0al (1994) Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 89(4):285\u2013288","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"581_CR45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004714-199002000-00024","volume":"10","author":"R Yassa","year":"1990","unstructured":"Yassa R et\u00a0al (1990) Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial. J\u00a0Clin Psychopharmacol 10(1):66\u201368","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"581_CR46","first-page":"357","volume":"51","author":"PI Rosebush","year":"1990","unstructured":"Rosebush PI et\u00a0al (1990) Catatonic syndrome in a\u00a0general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J\u00a0Clin Psychiatry 51(9):357\u2013362","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"581_CR47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0253-7176.207338","volume":"39","author":"SP Swain","year":"2017","unstructured":"Swain SP, Behura SS, Dash MK (2017) The phenomenology and treatment response in catatonia: a hospital based descriptive study. Indian J Psychol Med 39(3):323\u2013329","journal-title":"Indian J Psychol Med"},{"issue":"1","key":"581_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YCT.0b013e31829a01d3","volume":"30","author":"P Cristancho","year":"2014","unstructured":"Cristancho P et\u00a0al (2014) Successful use of right unilateral ECT for catatonia: a\u00a0case series. J\u00a0Ect 30(1):69\u201372","journal-title":"J Ect"},{"issue":"1","key":"581_CR49","first-page":"21","volume":"45","author":"K Girish","year":"2003","unstructured":"Girish K, Gill NS (2003) Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry 45(1):21\u201325","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"581_CR50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/YCT.0000000000000185","volume":"31","author":"JL Kugler","year":"2015","unstructured":"Kugler JL et\u00a0al (2015) Treatment of catatonia with ultrabrief right unilateral electroconvulsive therapy: a case series. J\u00a0Ect 31(3):192\u2013196","journal-title":"J Ect"},{"issue":"5","key":"581_CR51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00406-011-0285-4","volume":"262","author":"D Raveendranathan","year":"2012","unstructured":"Raveendranathan D, Narayanaswamy JC, Reddi SV (2012) Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur Arch Psychiatry Clin Neurosci 262(5):425\u2013430","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"581_CR52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-0327(93)90015-C","volume":"29","author":"BM Rohland","year":"1993","unstructured":"Rohland BM, Carroll BT, Jacoby RG (1993) ECT in the treatment of the catatonic syndrome. J\u00a0Affect Disord 29(4):255\u2013261","journal-title":"J Affect Disord"},{"issue":"4","key":"581_CR53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/YCT.0b013e3181c18a13","volume":"26","author":"JA Waarde van","year":"2010","unstructured":"van Waarde JA et\u00a0al (2010) Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. J\u00a0Ect 26(4):248\u2013252","journal-title":"J Ect"},{"issue":"Suppl 2","key":"581_CR54","first-page":"25","volume":"62","author":"F Martenyi","year":"2001","unstructured":"Martenyi F et\u00a0al (2001) An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. J\u00a0Clin Psychiatry 62(Suppl 2):25\u201327","journal-title":"J Clin Psychiatry"},{"key":"581_CR55","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/NDT.S52311","volume":"9","author":"B Yoshimura","year":"2013","unstructured":"Yoshimura B et\u00a0al (2013) Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat 9:1565\u20131571","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"581_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-014-3807-8","volume":"232","author":"FU Lang","year":"2015","unstructured":"Lang FU et\u00a0al (2015) Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma. Psychopharmacology (Berl) 232(1):1\u20135","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"581_CR57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archpsyc.1977.01770200085010","volume":"34","author":"AJ Gelenberg","year":"1977","unstructured":"Gelenberg AJ, Mandel MR (1977) Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 34(8):947\u2013950","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"581_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ncl.2010.10.002","volume":"29","author":"SN Caroff","year":"2011","unstructured":"Caroff SN et\u00a0al (2011) Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol Clin 29(1):127\u2013148, viii","journal-title":"Neurol Clin"},{"issue":"Suppl 1","key":"581_CR59","first-page":"S54","volume":"37","author":"S Stubner","year":"2004","unstructured":"Stubner S et\u00a0al (2004) Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry 37(Suppl 1):S54\u2013S64","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"581_CR60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S1092852900013419","volume":"5","author":"DA White","year":"2000","unstructured":"White DA, Robins AH (2000) An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS Spectr 5(7):58\u201365","journal-title":"CNS Spectr."},{"key":"581_CR61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1176\/appi.books.9781615377176.lg11","volume-title":"Catatonia: from psychopathology to neurobiology","author":"A Lopez-Canino","year":"2004","unstructured":"Lopez-Canino A, Francis A (2004) Drug-induced catatonia. In: Caroff SN, Francis A, Fricchione GL (Hrsg) Catatonia: from psychopathology to neurobiology. American Psychiatric Press, Washington, D.C., S 129\u2013139"},{"issue":"7","key":"581_CR62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2007-996393","volume":"64","author":"G Stober","year":"1996","unstructured":"Stober G et\u00a0al (1996) Manneristic catatonia. A psychotropic drug refractory chronic progressive course. Fortschr Neurol Psychiatr 64(7):250\u2013260","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"6","key":"581_CR63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4088\/JCP.v58n0603","volume":"58","author":"JK Stanilla","year":"1997","unstructured":"Stanilla JK, de Leon J, Simpson GM (1997) Clozapine withdrawal resulting in delirium with psychosis: a\u00a0report of three cases. J\u00a0Clin Psychiatry 58(6):252\u2013255","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"581_CR64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.wnf.0000145506.99636.1b","volume":"27","author":"AW Yeh","year":"2004","unstructured":"Yeh AW et\u00a0al (2004) Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a\u00a0case report. Clin Neuropharmacol 27(5):216\u2013218","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"581_CR65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00048670802653398","volume":"43","author":"T Bastiampillai","year":"2009","unstructured":"Bastiampillai T, Forooziya F, Dhillon R (2009) Clozapine-withdrawal catatonia. Aust N Z J Psychiatry 43(3):283\u2013284","journal-title":"Aust N Z J Psychiatry"},{"issue":"Suppl 4","key":"581_CR66","first-page":"12","volume":"63","author":"SN Caroff","year":"2002","unstructured":"Caroff SN et\u00a0al (2002) Movement disorders associated with atypical antipsychotic drugs. J\u00a0Clin Psychiatry 63(Suppl 4):12\u201319","journal-title":"J Clin Psychiatry"},{"key":"581_CR67","first-page":"211","volume":"5","author":"J Segal","year":"2001","unstructured":"Segal J, Isaacs MD, Berk M (2001) Neuroleptic malignant syndrome: possible induction by olanzapine in a\u00a0case with relapsing catatonia. Int J Psychiatry 5:211\u2013213","journal-title":"Int J Psychiatry"},{"issue":"10","key":"581_CR68","first-page":"1411","volume":"162","author":"S Pedersen","year":"2000","unstructured":"Pedersen S, Andreassen MD (2000) Malignant neuroleptic syndrome. Treatment and resumption of the treatment in malignant neuroleptic syndrome. Ugeskr Laeg 162(10):1411\u20131412","journal-title":"Ugeskr. Laeg."},{"issue":"3","key":"581_CR69","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00115-017-0463-3","volume":"89","author":"R Knorr","year":"2018","unstructured":"Knorr R, Schollkopf J, Haen E (2018) Neuroleptic malignant syndrome. Nervenarzt 89(3):300\u2013310","journal-title":"Nervenarzt"},{"issue":"6","key":"581_CR70","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","volume":"164","author":"JR Strawn","year":"2007","unstructured":"Strawn JR, Keck PE Jr., Caroff SN (2007) Neuroleptic malignant syndrome. Am J Psychiatry 164(6):870\u2013876","journal-title":"Am J Psychiatry"},{"issue":"1","key":"581_CR71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","volume":"15","author":"M Belvederi Murri","year":"2015","unstructured":"Belvederi Murri M et al (2015) Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R\u00a0D 15(1):45\u201362","journal-title":"Drugs R D"},{"issue":"1","key":"581_CR72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.111.105189","volume":"201","author":"JN Trollor","year":"2012","unstructured":"Trollor JN, Chen X, Chitty K, Sachdev PS (2012) Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry 201(1):52\u201356","journal-title":"Br J Psychiatry"},{"issue":"3","key":"581_CR73","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11126-014-9291-9","volume":"85","author":"E Anbalagan","year":"2014","unstructured":"Anbalagan E, Ithman M, Lauriello J (2014) Rechallenging clozapine after neuroleptic malignant syndrome. Psychiatr\u00a0Q 85(3):345\u2013348","journal-title":"Psychiatr Q"},{"issue":"1","key":"581_CR74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/acps.12222","volume":"130","author":"YP Su","year":"2014","unstructured":"Su YP et\u00a0al (2014) Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome. Acta Psychiatr Scand 130(1):52\u201360","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"581_CR75","first-page":"213","volume":"27","author":"SC Mann","year":"2001","unstructured":"Mann SC et\u00a0al (2001) Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature. Encephale 27(3):213\u2013216","journal-title":"Encephale"},{"issue":"11","key":"581_CR76","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1176\/ajp.143.11.1374","volume":"143","author":"SC Mann","year":"1986","unstructured":"Mann SC et\u00a0al (1986) Lethal catatonia. Am J Psychiatry 143(11):1374\u20131381","journal-title":"Am J Psychiatry"},{"issue":"1","key":"581_CR77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02252624","volume":"6","author":"J Kornhuber","year":"1993","unstructured":"Kornhuber J, Weller M, Riederer P (1993) Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis. J\u00a0Neural Transm Park Dis Dement Sect 6(1):63\u201372","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"3","key":"581_CR78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-015-3864-7","volume":"232","author":"SN Caroff","year":"2015","unstructured":"Caroff SN, Mann SC, Campbell EC (2015) Neuroleptic malignant syndrome and the catatonic dilemma. Psychopharmacology (Berl) 232(3):661\u2013662","journal-title":"Psychopharmacology (Berl)"},{"key":"581_CR79","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-18533-5","volume-title":"Bewegungsst\u00f6rungen bei psychischen Erkrankungen","author":"T Jahn","year":"2004","unstructured":"Jahn T (2004) Bewegungsst\u00f6rungen bei psychischen Erkrankungen. Springer, Heidelberg"},{"issue":"6","key":"581_CR80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/106002808802200606","volume":"22","author":"AJ Wells","year":"1988","unstructured":"Wells AJ, Sommi RW, Crismon ML (1988) Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intell Clin Pharm 22(6):475\u2013480","journal-title":"Drug Intell Clin Pharm"},{"key":"581_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx157","author":"M Solmi","year":"2017","unstructured":"Solmi M et al (2017) Prevalence of catatonia and its moderators in clinical samples: results from a\u00a0meta-analysis and meta-regression analysis. Schizophr Bull. https:\/\/doi.org\/10.1093\/schbul\/sbx157","journal-title":"Schizophr Bull"},{"key":"581_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-017-0375-2","author":"D Hirjak","year":"2017","unstructured":"Hirjak D et\u00a0al (2017) Genuine motor phenomena in schizophrenic psychoses: theoretical background and definition of context. Nervenarzt. https:\/\/doi.org\/10.1007\/s00115-017-0375-2","journal-title":"Nervenarzt"},{"issue":"3","key":"581_CR83","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1176\/jnp.3.3.334","volume":"3","author":"D Rogers","year":"1991","unstructured":"Rogers D (1991) Catatonia: a\u00a0contemporary approach. J\u00a0Neuropsychiatry Clin Neurosci 3(3):334\u2013340","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"581_CR84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","volume":"93","author":"G Bush","year":"1996","unstructured":"Bush G et\u00a0al (1996) Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 93(2):129\u2013136","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"581_CR85","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00115-016-0136-7","volume":"88","author":"D Hirjak","year":"2016","unstructured":"Hirjak D et al (2016) NCR-Skala \u2013 Deutsche Version der Northoff Catatonia Rating Scale (NCRS-dv) \u2013 Ein validiertes Messinstrument zur Erfassung katatoner Symptome. Nervenarzt 88(7):787\u2013796. https:\/\/doi.org\/10.1007\/s00115-016-0136-7","journal-title":"Nervenarzt"},{"issue":"Suppl 1","key":"581_CR86","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1055\/s-2004-834747","volume":"32","author":"P Braunig","year":"2005","unstructured":"Braunig P, Kruger S (2005) Catatonia. Psychiatr Prax 32(Suppl 1):S7\u201324","journal-title":"Psychiatr Prax"},{"issue":"2","key":"581_CR87","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0010-440X(00)90148-2","volume":"41","author":"P Braunig","year":"2000","unstructured":"Braunig P et\u00a0al (2000) The catatonia rating scale I \u2013 development, reliability, and use. Compr Psychiatry 41(2):147\u2013158","journal-title":"Compr Psychiatry"},{"issue":"6","key":"581_CR88","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0010-440X(03)00108-1","volume":"44","author":"S Kruger","year":"2003","unstructured":"Kruger S et\u00a0al (2003) Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry 44(6):472\u2013482","journal-title":"Compr Psychiatry"},{"issue":"3","key":"581_CR89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/1817-1745.147611","volume":"9","author":"CM Sharma","year":"2014","unstructured":"Sharma CM et\u00a0al (2014) Role of lorazepam challenge test in childhood catatonia. J\u00a0Pediatr Neurosci 9(3):301\u2013303","journal-title":"J Pediatr Neurosci"},{"issue":"2","key":"581_CR90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00004714-198604000-00025","volume":"6","author":"JP McEvoy","year":"1986","unstructured":"McEvoy JP (1986) Relief from catatonic immobility can be maintained. J\u00a0Clin Psychopharmacol 6(2):126\u2013127","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"581_CR91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/2319-4170.107162","volume":"36","author":"YC Huang","year":"2013","unstructured":"Huang YC et\u00a0al (2013) Rapid relief of catatonia in mood disorder by lorazepam and diazepam. Biomed\u00a0J 36(1):35\u201339","journal-title":"Biomed J"},{"issue":"3","key":"581_CR92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.WNF.0000221908.56361.C7","volume":"29","author":"YY Hung","year":"2006","unstructured":"Hung YY, Huang TL (2006) Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 29(3):144\u2013147","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"581_CR93","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bdi.12348","volume":"17","author":"P Medda","year":"2015","unstructured":"Medda P et\u00a0al (2015) Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy. Bipolar Disord 17(8):892\u2013901","journal-title":"Bipolar Disord"},{"key":"581_CR94","volume-title":"Die psychiatrische Notfallmedizin","author":"A Sartorius","year":"2017","unstructured":"Sartorius A (2017) Elektrokrampftherapie in der Akutpsychiatrie. In: Hewer W, R\u00f6ssler W, Messer T (Hrsg) Die psychiatrische Notfallmedizin. Urban & Fischer, M\u00fcnchen, Jena"},{"issue":"9","key":"581_CR95","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00115-004-1700-0","volume":"75","author":"R Rupprecht","year":"2004","unstructured":"Rupprecht R et\u00a0al (2004) Considerations in the combination of clozapine and benzodiazepines. Nervenarzt 75(9):857\u2013860","journal-title":"Nervenarzt"},{"issue":"4","key":"581_CR96","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/YCT.0000000000000433","volume":"33","author":"A Unal","year":"2017","unstructured":"Unal A et\u00a0al (2017) The use of lorazepam and electroconvulsive therapy in the treatment of catatonia: treatment characteristics and outcomes in 60 patients. J\u00a0Ect 33(4):290\u2013293","journal-title":"J Ect"},{"issue":"3","key":"581_CR97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","volume":"15","author":"G Perugi","year":"2017","unstructured":"Perugi G et al (2017) The role of Electroconvulsive Therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features. Curr Neuropharmacol 15(3):359\u2013371","journal-title":"Curr Neuropharmacol"},{"key":"581_CR98","first-page":"234","volume":"18","author":"N Bartolommei","year":"2012","unstructured":"Bartolommei N et\u00a0al (2012) Catatonia: a\u00a0critical review and therapeutic recommendations. J\u00a0Psychopathol 18:234\u2013246","journal-title":"J. Psychopathol."},{"issue":"4","key":"581_CR99","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.62.4.404","volume":"62","author":"G Northoff","year":"1997","unstructured":"Northoff G, Eckert J, Fritze J (1997) Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J\u00a0Neurol Neurosurg Psychiatr 62(4):404\u2013406","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"581_CR100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1192\/bjp.158.3.437","volume":"158","author":"T Mahmood","year":"1991","unstructured":"Mahmood T (1991) Bromocriptine in catatonic stupor. Br J Psychiatry 158:437\u2013438","journal-title":"Br J Psychiatry"},{"issue":"6","key":"581_CR101","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1192\/bjp.164.6.847b","volume":"164","author":"M Franz","year":"1994","unstructured":"Franz M, Gallhofer B, Kanzow WT (1994) Treatment of catatonia with intravenous biperidene. Br J Psychiatry 164(6):847\u2013848","journal-title":"Br J Psychiatry"},{"issue":"2","key":"581_CR102","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/jnp.2007.19.2.197","volume":"19","author":"R Bowers","year":"2007","unstructured":"Bowers R, Ajit SS (2007) Is there a\u00a0role for valproic acid in the treatment of catatonia? J\u00a0Neuropsychiatry Clin Neurosci 19(2):197\u2013198","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"581_CR103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1176\/jnp.2006.18.2.234","volume":"18","author":"WW McDaniel","year":"2006","unstructured":"McDaniel WW, Spiegel DR, Sahota AK (2006) Topiramate effect in catatonia: a\u00a0case series. J\u00a0Neuropsychiatry Clin Neurosci 18(2):234\u2013238","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"581_CR104","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1176\/ajp.145.3.361","volume":"145","author":"HW Rankel","year":"1988","unstructured":"Rankel HW, Rankel LE (1988) Carbamazepine in the treatment of catatonia. Am J Psychiatry 145(3):361\u2013362","journal-title":"Am J Psychiatry"},{"key":"581_CR105","first-page":"235","volume":"p","author":"OH Arnold","year":"1952","unstructured":"Arnold OH, Stepan H (1952) Untersuchungen zur Frage der akuten t\u00f6dliche Katatonie. Wien Z Nervenheilkd Grenzgeb p:235\u2013287","journal-title":"Wien. Z. Nervenheilkd Grenzgeb."}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0581-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:20:20Z","timestamp":1751804420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0581-6"}},"subtitle":["Katatone Symptome und malignes neuroleptisches Syndrom","Catatonic symptoms and neuroleptic malignant syndrome"],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0581-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"20 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Hirjak, A.\u00a0Sartorius, K.\u00a0M.\u00a0Kubera und R.C.\u00a0Wolf geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}